Understanding the Perspective of Youths on Undergoing Metabolic Monitoring While on Second-Generation Antipsychotics: Challenges, Insight, and Implications

被引:0
|
作者
Aouira, Nisreen [1 ,7 ]
Khan, Sohil [1 ,2 ,3 ,4 ]
Heussler, Helen [2 ,5 ]
Haywood, Alison [1 ,2 ]
Karaksha, Abdullah [1 ]
Bor, William [2 ,5 ,6 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast, Australia
[2] Univ Queensland, Mater Res Inst, Brisbane, Australia
[3] Prasanna Inst Publ Hlth, Manipal, India
[4] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Manipal, India
[5] Childrens Hlth Queensland Hosp & Hlth Serv, Brisbane, Australia
[6] Queensland Hlth, Ctr Childrens Hlth Res, Child & Youth Mental Hlth Serv, Brisbane, Australia
[7] Griffith Univ, Menzies Hlth Inst Queensland, Sch Pharm & Med Sci, Gold Coast 4222, Australia
关键词
youths; perspective; antipsychotics; barriers; suggestions; health; PSYCHOTROPIC MEDICATION; PHYSICAL-ACTIVITY; EXPERIENCE; BARRIERS; DEPRESSION; ADOLESCENTS; CHILDREN; CARE; PARTICIPATION; PERCEPTIONS;
D O I
10.1089/cap.2023.0016
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: Prescription of second-generation antipsychotics (SGAs) in youths is rapidly increasing globally, despite the potential for significant adverse effects and long-term health consequences. A known adverse reaction resulting from SGAs is metabolic syndrome (MS). Youths exposed to antipsychotics are at higher risk than adults for adverse drug reactions, including adverse events such as MS (with weight gain as the most significant adverse outcome) and other long-term endocrinological abnormalities. This study aimed to explore the experiences of young patients on factors impacting barriers to metabolic monitoring of SGAs and the strategies to address those barriers thereby providing further guidance on policy and service delivery.Methods: Semi-structured interviews were conducted with patients (youths who were prescribed SGAs) who attended Child and Youth Mental Health Services. The interviews focused on barriers to monitoring and strategies to enhance rates of monitoring that could be customized across study sites.Results: Young patients revealed that none of them had any concerns or objections to receiving anthropometric metabolic measurements. However, they seemed concerned to undergo blood tests as part of the metabolic monitoring process. Specifically, youths cited their fear of the needles as barrier to undergo the required blood tests. Youths have also reported that their dislike to healthy foods and exercise being the most common challenge they face while trying to engage in a healthy lifestyle to manage the SGAs resulted weight gain.Conclusion: Prescribers are recommended to actively engage young patients about the expected SGAs-induced adverse effects, the importance of conducting metabolic monitoring, and how to prevent and minimize the expected adverse effects from the start of initiating SGAs. This could be a vital step toward a successful treatment as the insight of youths into the details of the chosen treatment can play a significant role into treatment adherence and recovery.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [31] Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents
    Correll, CU
    Penzner, JB
    Parikh, UH
    Mughal, T
    Javed, T
    Carbon, M
    Malhotra, AK
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2006, 15 (01) : 177 - +
  • [32] Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics
    Rodday, Angie Mae
    Parsons, Susan K.
    Mankiw, Catherine
    Correll, Christoph U.
    Robb, Adelaide S.
    Zima, Bonnie T.
    Saunders, Tully S.
    Leslie, Laurel K.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (04) : 351 - 361
  • [33] Glucose monitoring in new users of second-generation antipsychotics in older people
    Ndukwe, Henry C.
    Nishtala, Prasad S.
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2017, 70 : 136 - 140
  • [34] Monitoring of Patients on Second-Generation Antipsychotics: A National Survey of Child Psychiatrists
    McLaren, Jennifer L.
    Brunette, Mary F.
    McHugo, Gregory J.
    Drake, Robert E.
    Daviss, William B.
    PSYCHIATRIC SERVICES, 2017, 68 (09) : 958 - 961
  • [35] Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naive French Canadian Patients
    Roy, Genevieve
    Bedard, Alain
    Desmarais, Paul-Andre
    Jourdain, France
    Allen, Sylvie
    Michaud, Danielle
    Ben Amor, Leila
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 479 - 487
  • [36] Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics
    DelMonte, M. T.
    Bostwick, J. R.
    Bess, J. D.
    Dalack, G. W.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (06) : 668 - 673
  • [37] The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics
    Cohen, Sydnee
    Bostwick, Jolene R.
    Marshall, Vincent D.
    Kruse, Kathleen
    Dalack, Gregory W.
    Patel, Paresh
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1398 - 1404
  • [38] Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents
    Sanyal, Swarnava
    Calarge, Chadi A.
    Rowan, Paul J.
    Aparasu, Rajender R.
    Abughosh, Susan
    Chen, Hua
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 165 : 170 - 173
  • [39] Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention
    Lee, J.
    Dalack, G. W.
    Casher, M. I.
    Eappen, S. A.
    Bostwick, J. R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (02) : 209 - 213
  • [40] The Effectiveness of a Computer Reminder System for Laboratory Monitoring of Metabolic Syndrome in Schizophrenic Outpatients Using Second-generation Antipsychotics
    Lai, C. -L.
    Chan, H. -Y.
    Pan, Y. -J.
    Chen, C. -H.
    PHARMACOPSYCHIATRY, 2015, 48 (01) : 25 - 29